Drug Trial Radar · NCT05388825
Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction
Last checked: Nov 20, 2026Latest source record: Feb 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
84
Actual
Start
Aug 1, 2022
Primary completion
Jan 4, 2023
Study completion Feb 17, 2023
Sponsor
- Lead sponsor
- Vigonvita Life SciencesIndustry
- Sponsor type
- Industry
- First posted
- May 24, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a randomized, double-blind, placebo-controlled, two-cohort, three-cycle crossover (at least a 5-day cleaning period per cycle), and a multicenter clinical trial design.
Conditions
- Erectile Dysfunction
Interventions
TPN171H 2.5mgDrug
TPN171H 2.5mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)
TPN171H 5mgDrug
TPN171H 5mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)
TPN171H 10mgDrug
TPN171H 10mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)
Placebo 5mgDrug
Placebo 5mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)
Placebo 10mgDrug
Placebo 10mg is recommended to take warm water on an empty stomach (2 hours or more after dinner)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Duration of penile erections of greater than or equal to 60% rigidity as assessed by penile plethysmography (RigiScan PlusTM).Time frame: Baseline and during audiovisual sexual stimulation(60minutes)
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Henan Provincial People's Hospital
Zhenzhou, Henan, China
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
The First Hospital of Jilin University
Changchun, Jinlin, China
The Second Hospital of Dalian Medical University
Dalian, Liaoning, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.